Sherlock gets $5M to advance COVID-19 self-test platform

By staff writers

December 16, 2020 -- Sherlock Biosciences has received a $5 million grant to advance its internal splint-pairing expression cassette translation reaction (INSPECTR) platform for a COVID-19 self-test.

The Bill & Melinda Gates Foundation provided the grant for the instrument-free, synthetic biology-based molecular diagnostic platform that can be used at home and at room temperature. The platform can be adapted to work on a simple paper strip test or to provide an electrochemical readout that can be read with a mobile phone.

The grant also will be used to support Sherlock's development of an over-the-counter disposable product that can be used to detect SARS-CoV-2, similar to a home pregnancy test. Pending approval, the company is on track to launch the test in mid-2021.

Sherlock, D-HH to study CRISPR SARS-CoV-2 kit
Sherlock Biosciences and Dartmouth-Hitchcock Health (D-HH) will study Sherlock's CRISPR SARS-CoV-2 kit, which recently received emergency use authorization...
Sherlock, Binx to develop rapid CRISPR COVID-19 test
Sherlock Biosciences and Binx Health have partnered to create a rapid, point-of-care test for COVID-19 utilizing CRISPR technology.
Sherlock gets $7.5M to create COVID-19 diagnostics
Open Philanthropy has advanced $7.5 million in grant funding to engineering biology company Sherlock Biosciences for diagnostics related to the novel...
Sherlock's novel CRISPR coronavirus test cleared in U.S.
Engineering biology company Sherlock Biosciences has received emergency use authorization from the U.S. Food and Drug Administration for a detection kit...

Copyright © 2020

Last Updated ls 12/16/2020 4:10:29 PM

Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current